NEW YORK (GenomeWeb) – Quest Diagnostics today posted a 7 percent rise in fourth quarter revenues, topping analysts' estimates and helping drive an increase in its net income.

Quest's revenues from continuing operations were $1.88 billion for the three-month period ended Dec. 31, compared with year-ago revenues of $1.76 billion. Analysts had expected revenues of $1.85 billion.

The company said revenues from diagnostic information services climbed 7 percent over last year, while test volume around 9 percent. Revenue per requisition was nearly 2 percent lower than a year ago.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

A genome-wide association study highlights a potential role for hair follicles in acne risk, according to New Scientist.

Newsday reports that breast cancer genetic testing guidelines for are out of date and may miss individuals.

In Cell this week: gene editing-based strategy to screen for immune system regulators, ancient plague patterns, and more.

Publication of He Jiankui's work on gene-edited infants would raise ethical concerns for journals, Wired and others report.